Da Hee Han, PharmD

Most Recent Articles by Da Hee Han, PharmD

Rezafungin Gets Fast Track, QIDP Status for Prevention of Invasive Fungal Infections

Rezafungin Gets Fast Track, QIDP Status for Prevention of Invasive Fungal Infections

By

The Phase 3 ReSPECT prophylaxis trial of rezafungin in patients undergoing allogeneic bone marrow transplantation is anticipated to start in the first quarter of 2019.

Authorized Generics of Epclusa, Harvoni Will Soon Be Available for HCV Treatment

Authorized Generics of Epclusa, Harvoni Will Soon Be Available for HCV Treatment

By

The list price for the generics is $24,000 for the most common course of therapy.

FDA Approves Two New Oral Treatments for HIV-1 Infection

FDA Approves Two New Oral Treatments for HIV-1 Infection

By

Delstrigo is approved as a complete regimen whereas Pifeltro is to be administered in combination with other antiretrovirals.

Eravacycline Approved for the Treatment of Complicated Intra-Abdominal Infections

Eravacycline Approved for the Treatment of Complicated Intra-Abdominal Infections

By

Eravacycline was well-tolerated in clinical trials and achieved high cure rates in patients with Gram-negative pathogens (including resistant strains).

Does Adolescent Vaccination Increase Primary Ovarian Insufficiency Risk?

Does Adolescent Vaccination Increase Primary Ovarian Insufficiency Risk?

By

For this study, researchers investigated the incidence of primary ovarian insufficiency incidence and estimated risk for POI after vaccination with human papillomavirus, Tdap, influenza and meningococcal conjugate using Kaiser Permanente Northwest electronic health records from 2006 to 2014.

More Articles by Da Hee Han, PharmD

Sign Up for Free e-newsletters